Towa Pharmaceutical Co., Ltd. (TWAPF)
25.33
0.00 (0.00%)
USD |
OTCM |
Apr 15, 16:00
Price Chart
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | 1.247B |
| 52 Week High (Daily) | |
| 52 Week Low (Daily) | |
| All-Time High (Daily) | |
| Year to Date Total Returns (Daily) | |
| 1 Month Total Returns (Daily) | |
| 1 Year Total Returns (Daily) | 53.62% |
| Valuation | |
| PE Ratio | 8.767 |
| PE Ratio (Forward) | |
| PS Ratio | 0.6914 |
| Price to Book Value | 1.030 |
| EV to EBITDA | |
| Dividend | |
|---|---|
| Dividend | 0.2502 |
| Dividend Yield (Forward) | |
| Financials | |
| Revenue (5 Year Growth) | |
| Revenue (Quarterly YoY Growth) | |
| EPS Diluted (5 Year Growth) | |
| EPS Diluted (Quarterly YoY Growth) | |
| Debt to Equity Ratio | 1.232 |
| Return on Equity | |
| Return on Assets | |
| Risk | |
| Beta (5Y) | |
| Max Drawdown (5Y) | -- |
Profile
| Towa Pharmaceutical Co., Ltd. engages in the manufacture and distribution of pharmaceutical products. Its products include neurological and anti-allergic drugs, cardiovascular and respiratory drugs, gastrointestinal drugs, antibiotics and chemotherapeutic drugs, vitamins, hormone drugs, and other metabolic drugs. It operates through Domestic and Overseas Segments. The Domestic segment manufacture and sale of pharmaceuticals directly to medical institutions through sales offices, as well as to agents, pharmaceutical wholesalers, and other pharmaceutical manufacturers. The Overseas segment engages in generic pharmaceutical sales business; contract research; and development and manufacturing business. The company was founded in June 1951 and is headquartered in Kadoma, Japan. |
| URL | https://www.towayakuhin.co.jp |
| Investor Relations URL | N/A |
| HQ State/Province | Osaka |
| Sector | Health Care |
| Industry | Pharmaceuticals |
| Next Earnings Release | May. 14, 2026 |
| Last Earnings Release | Feb. 13, 2026 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | Mar. 31, 2026 |
Profile
| Towa Pharmaceutical Co., Ltd. engages in the manufacture and distribution of pharmaceutical products. Its products include neurological and anti-allergic drugs, cardiovascular and respiratory drugs, gastrointestinal drugs, antibiotics and chemotherapeutic drugs, vitamins, hormone drugs, and other metabolic drugs. It operates through Domestic and Overseas Segments. The Domestic segment manufacture and sale of pharmaceuticals directly to medical institutions through sales offices, as well as to agents, pharmaceutical wholesalers, and other pharmaceutical manufacturers. The Overseas segment engages in generic pharmaceutical sales business; contract research; and development and manufacturing business. The company was founded in June 1951 and is headquartered in Kadoma, Japan. |
| URL | https://www.towayakuhin.co.jp |
| Investor Relations URL | N/A |
| HQ State/Province | Osaka |
| Sector | Health Care |
| Industry | Pharmaceuticals |
| Next Earnings Release | May. 14, 2026 |
| Last Earnings Release | Feb. 13, 2026 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | Mar. 31, 2026 |